The Fermiscan Test is a safe, non-invasive technology that utilises X-ray diffraction of hair fibres to screen and monitor women of all ages for breast cancer. The Fermiscan Test will be available for women in Australia in 2008 and Fermiscan is also commencing further clinical trials and regulatory approval processes in the US.
The Fermiscan Test requires individuals to supply 20 strands of untreated scalp hair with a minimum length of 30 mm. The hairs are then exposed to a finely focused X-ray beam for up to 30 s. The diffracted X-rays are collected as an image which is then analysed to determine if subtle changes are present in the image that are indicative of the presence of breast cancer.
Phone: 02 9245 4460
Invent Biotechnologies Minute Single Cell Nuclei Kits
The Invent Biotechnologies Minute Single Cell Nuclei Kits use proprietary spin column-based...
MP Biomedicals MagBeads FastDNA MaxPure Kit for Feces and Fecal Preservation Solution
MP Biomedicals MagBeads FastDNA MaxPure Kit for Feces is a magnetic bead-based solution...
Enzo Life Sciences Histamine ELISA Kit
The Enzo Life Sciences Histamine ELISA Kit is engineered to enable the ultra-sensitive detection...
